Alternative data

Catalysts and litigation

One regulatory event or deadline, with source evidence and revisions

4 endpointsFrom 1 creditHistory from Oct 2026

Try it

curl https://api.gloom.sh/v1/catalysts \
  -H "Authorization: Bearer $GLOOM_DATASETS_KEY"
Response
{
  "data": {
    "events": [
      {
        "source": "fda_approvals",
        "agency": "FDA",
        "jurisdiction": "US",
        "country": "US",
        "status": "approved",
        "summary": "Labeling",
        "parties": [
          {
            "name": "CHEPLAPHARM",
            "role": "current application sponsor",
            "entityId": null,
            "ticker": null,
            "exchange": null,
            "resolution": "unresolved",
            "confidence": 0
          }
        ],
        "observedAt": "2026-10-04T01:00:00.000Z",
        "language": "en",
        "confidence": 1,
        "externalId": "NDA020766:SUPPL:22",
        "title": "XENICAL: supplement approval",
        "type": "approval",
        "sourceUrl": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020766",
        "sourceDocumentId": "NDA020766",
        "announcedDate": "2007-01-05",
        "effectiveDate": "2007-01-05",
        "datePrecision": {
          "announced": "day",
          "effective": "day"
        },
        "quote": "{\n  \"submission_type\": \"SUPPL\",\n  \"submission_number\": \"22\",\n  \"submission_status\": \"AP\",\n  \"submission_status_date\": \"20070105\",\n  \"review_priority\": \"STANDARD\",\n  \"submission_class_code\": \"LABELING\",\n  \"submission_class_code_description\": \"Labeling\",\n  \"application_docs\": [\n    {\n      \"id\": \"13381\",\n      \"url\": \"http://www.accessdata.fda.gov/drugsatfda_docs/label/2007/020766s022lbl.pdf\",\n      \"date\": \"20070108\",\n      \"type\": \"Label\"\n    },\n    {\n      \"id\": \"25751\",\n      \"url\": \"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2007/020766s022_ltr.pdf\",\n      \"date\": \"20070112\",\n      \"type\": \"Letter\"\n    }\n  ]\n}",
        "metadata": {
          "extraction": "deterministic source fields",
          "applicationNumber": "NDA020766",
          "attributionBasis": "Current sponsor of the application; not necessarily the historical sponsor on the approval action date",
          "submissionType": "SUPPL",
          "submissionNumber": "22",
          "products": [
            {
              "product_number": "001",
              "reference_drug": "Yes",
              "brand_name": "XENICAL",
              "active_ingredients": [
                {
                  "name": "ORLISTAT",
                  "strength": "120MG"
                }
              ],
              "reference_standard": "Yes",
              "dosage_form": "CAPSULE",
              "route": "ORAL",
              "marketing_status": "Prescription"
            }
          ],
          "reviewPriority": "STANDARD",
          "effectiveDateMeaning": "FDA approval action date"
        },
        "deadlineDate": null,
        "sector": null,
        "quoteOffset": 473,
        "quoteSourceLength": 677,
        "quoteMatchMode": "whitespace",
        "opinion": null,
        "sourcePublishedAt": null,
        "id": "59f68ff9ff738a132e6f1973eef3ba6f",
        "revisionId": "59f68ff9ff738a132e6f1973eef3ba6f:1",
        "revision": 1,
        "changes": [],
        "supersedesRevisionId": null,
        "firstSeenAt": "2026-10-04T01:00:00.000Z",
        "lastSeenAt": "2026-10-04T01:00:00.000Z"
      },
      {
        "source": "fda_approvals",
        "agency": "FDA",
        "jurisdiction": "US",
        "country": "US",
        "status": "approved",
        "summary": "Manufacturing (CMC)",
        "parties": [
          {
            "name": "CHEPLAPHARM",
            "role": "current application sponsor",
            "entityId": null,
            "ticker": null,
            "exchange": null,
            "resolution": "unresolved",
            "confidence": 0
          }
        ],
        "observedAt": "2026-10-04T01:00:00.000Z",
        "language": "en",
        "confidence": 1,
        "externalId": "NDA020766:SUPPL:14",
        "title": "XENICAL: supplement approval",
        "type": "approval",
        "sourceUrl": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020766",
        "sourceDocumentId": "NDA020766",
        "announcedDate": "2002-02-27",
        "effectiveDate": "2002-02-27",
        "datePrecision": {
          "announced": "day",
          "effective": "day"
        },
        "quote": "{\n  \"submission_type\": \"SUPPL\",\n  \"submission_number\": \"14\",\n  \"submission_status\": \"AP\",\n  \"submission_status_date\": \"20020227\",\n  \"review_priority\": \"PRIORITY\",\n  \"submission_class_code\": \"MANUF (CMC)\",\n  \"submission_class_code_description\": \"Manufacturing (CMC)\"\n}",
        "metadata": {
          "extraction": "deterministic source fields",
          "applicationNumber": "NDA020766",
          "attributionBasis": "Current sponsor of the application; not necessarily the historical sponsor on the approval action date",
          "submissionType": "SUPPL",
          "submissionNumber": "14",
          "products": [
            {
              "product_number": "001",
              "reference_drug": "Yes",
              "brand_name": "XENICAL",
              "active_ingredients": [
                {
                  "name": "ORLISTAT",
                  "strength": "120MG"
                }
              ],
              "reference_standard": "Yes",
              "dosage_form": "CAPSULE",
              "route": "ORAL",
              "marketing_status": "Prescription"
            }
          ],
          "reviewPriority": "PRIORITY",
          "effectiveDateMeaning": "FDA approval action date"
        },
        "deadlineDate": null,
        "sector": null,
        "quoteOffset": 473,
        "quoteSourceLength": 283,
        "quoteMatchMode": "whitespace",
        "opinion": null,
        "sourcePublishedAt": null,
        "id": "02044c98983fab923ea948fc388055c1",
        "revisionId": "02044c98983fab923ea948fc388055c1:1",
        "revision": 1,
        "changes": [],
        "supersedesRevisionId": null,
        "firstSeenAt": "2026-10-04T01:00:00.000Z",
        "lastSeenAt": "2026-10-04T01:00:00.000Z"
      },
      // … 3 more items
    ],
    "total": 5,
    "limit": 100,
    "offset": 0,
    "asOf": "2026-10-04T01:00:00.000Z",
    "filters": {
      "limit": 100
    },
    "coverage": {
      "totalEvents": 8,
      "linkedEvents": 0,
      "unresolvedParties": 0,
      "jurisdictions": [
        "US"
      ],
      "firstObservedAt": "2026-10-04T01:00:00.000Z",
      "lastObservedAt": "2026-10-04T01:00:00.000Z",
      "sources": []
    },
    "facets": {
      "types": [],
      "agencies": [],
      "countries": [],
      "sectors": [],
      "statuses": []
    }
  },
  "meta": {
    "dataset": "catalysts",
    "requestId": "sample-request",
    "asOf": null,
    "dataThrough": "2026-10-04T01:00:00.000Z",
    "historyStart": "2026-10-04T01:00:00.000Z",
    "updatedAt": "2026-10-04T01:00:00.000Z",
    "page": null,
    "next": null,
    "coverage": {
      "totalEvents": 8,
      "linkedEvents": 0,
      "jurisdictions": [
        "US"
      ]
    },
    "source": [
      {
        "attribution": "Government and regulatory publications"
      }
    ]
  }
}

Trimmed · 2026-10-04

Run it without a key: GET /v1/datasets/catalysts/sample

Endpoints

GET/v1/catalysts2 creditsGovernment-sourced catalysts and deadlines

Parameters

symbolstring
Company symbol; normalized to uppercase.
agencystring
countrystring
sectorstring
statusstring
sourcestring
searchstring
fromstring
Calendar date: YYYY-MM-DD.
tostring
Calendar date: YYYY-MM-DD.
limitinteger
1 to 200. Default 100.
cursorstring
Opaque: meta.page.nextCursor of the previous page. Bound to this route and query.
typestring
regulatoryclinicallitigationantitrustrecallsanctionsexport_controltariffrulemakingapprovaladvisoryadvisory-meetingpdufa
dateFieldstring
announcedeffectivedeadlineanyobserved
upcomingboolean
changedboolean
litigationboolean

from must be on or before to.

GET/v1/litigation/{symbol}2 creditsCompany litigation and regulatory events

Parameters

symbolstringrequired
Company symbol; normalized to uppercase.
limitinteger
1 to 200. Default 100.
cursorstring
Opaque: meta.page.nextCursor of the previous page. Bound to this route and query.
GET/v1/catalysts/events/{id}5 creditsCatalyst evidence and revisions

Parameters

idstringrequired
limitinteger
1 to 200. Default 100.
cursorstring
Opaque: meta.page.nextCursor of the previous page. Bound to this route and query.
GET/v1/catalysts/changes1 creditObserved catalyst revisions

Parameters

cursorstring
limitinteger
1 to 200.
sincestringrequired
Timestamp with timezone: YYYY-MM-DDTHH:mm:ssZ.

Sources

Government and regulatory publications

Use subject to Gloom Datasets terms.

Errors 304 · 400 · 401 · 402 · 403 · 404 · 429 · 503